Bg pattern

INTESTIFALK UNO 9 mg GASTRO-RESISTANT GRANULES

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use INTESTIFALK UNO 9 mg GASTRO-RESISTANT GRANULES

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Intestifalk Uno 9 mg Gastro-Resistant Granules

Budesonide

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the package leaflet:

  1. What is Intestifalk Uno granules and what is it used for
  2. What you need to know before you take Intestifalk Uno granules
  3. How to take Intestifalk Uno granules
  4. Possible side effects
  5. Storage of Intestifalk Uno granules
  6. Contents of the pack and other information

1. What is Intestifalk Uno granules and what is it used for

Intestifalk Uno granules contain the active substance budesonide, a type of steroid with local action to treat chronic inflammatory diseases of the intestine.

This medicine is used for the treatment of

  • Crohn's disease: mild to moderate acute episodes of chronic inflammation of the intestine with involvement of the lower part of the small intestine (ileum) and/or the upper part of the large intestine (ascending colon).

Acute episodes of microscopic colitis: a disease with subtypes of collagenous colitis and lymphocytic colitis, characterized by chronic inflammation of the large intestine that is usually accompanied by chronic watery diarrhea.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Intestifalk Uno granules

Do not takeIntestifalk Uno granules:

  • if you are allergicto budesonide or any of the other ingredients of this medicine (listed in section 6).
  • if you have severe liver disease(liver cirrhosis).

Warnings and precautions

Consult your doctor before starting to take Intestifalk Uno granules if you have:

  • tuberculosis.
  • high blood pressure.
  • diabetes or a family member has been diagnosed with diabetes.
  • bone fragility (osteoporosis).
  • stomach or duodenal ulcers (peptic ulcer).
  • increased pressure in the eye (glaucoma) or eye problems such as cataracts or if a family member has been diagnosed with glaucoma
  • severe liver problems

Intestifalk Uno granules are not suitable for patients with Crohn's disease that affects the upper gastrointestinal tract.

Sometimes this disease can cause symptoms outside the intestine (e.g., affecting the skin, eyes, and joints) that are unlikely to respond to this medicine.

The typical effects of cortisone preparations may occur, which can affect all parts of the body, particularly if you take this medicine at high doses and for prolonged periods (see section 4. Possible side effects).

Additional precautions during treatment with Intestifalk Uno granules:

  • Tell your doctor if you have an infection. The symptoms of some infections may be atypical or less marked.
  • Stay away from people who have chickenpox or shingles (herpes zoster) if you have not had them before. They can affect you severely. If you come into contact with chickenpox or shingles, see your doctor immediately.
  • Tell your doctor if you have not had measles yet.
  • If you are going to receive any vaccine, tell your doctor beforehand.
  • Tell your doctor that you are using this medicine in case of surgery.
  • If you have been treated with a more potent cortisone preparation before starting treatment with Intestifalk Uno granules, your symptoms may recur when switching medicines. If this happens, contact your doctor.
  • Contact your doctor if you experience blurred vision or other visual disturbances.

Taking Intestifalk Uno with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. In particular:

  • cardiac glycosidessuch as digoxin (medicines used to treat heart conditions)
  • diuretics(to eliminate excess fluid in your body)
  • ketoconazole or itraconazole(to treat fungal infections)
  • antibioticsto treat infections (such as clarithromycin)
  • carbamazepine(used in the treatment of epilepsy)
  • rifampicin(to treat tuberculosis)
  • estrogens or oral contraceptives
  • cimetidine(used to inhibit stomach acid production)

Some medicines may increase the effects of Intestifalk Uno granules, so your doctor will monitor you closely if you are taking these medicines (including some for HIV: ritonavir, cobicistat).

If you take cholestyramine(to treat high cholesterol and also used to treat diarrhea) or antacids(for indigestion) with Intestifalk Uno granules, take these medicines at least 2 hours apart.

Intestifalk Uno granules may affect the results of tests performed by your doctor or in a hospital. Tell your doctor that you are taking Intestifalk Uno granules before undergoing any test.

TakingIntestifalk Uno granuleswith food and drinks

Do notdrink grapefruit juiceduring treatment with this medicine, as it may alter its effects.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.

You should only take Intestifalk Uno granules during pregnancy if your doctor advises you to.

Budesonide passes into breast milk in small amounts. If you are breastfeeding, you should only take Intestifalk Uno granules if your doctor advises you to.

Driving and using machines

It is unlikely that Intestifalk Uno granules will affect your ability to drive or use machines.

Intestifalk Uno granules contain sucrose, lactose, and sorbitol

If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.

This medicine contains 900 mg of sorbitol in each sachet. Sorbitol is a source of fructose. If your doctor has told you that you have an intolerance to some sugars or have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which the person cannot break down fructose, consult with your doctor before taking or receiving this medicine.

3. How to take Intestifalk Uno granules

Follow the instructions for administration of this medicine exactly as prescribed by your doctor.

If you are unsure, consult your doctor or pharmacist again.

The recommended dose is:

Crohn's disease and microscopic colitis

Adults

(over 18 years old)

Take one sachet in the morning, unless your doctor advises otherwise.

Use in children and adolescents

Intestifalk Uno granules should not be used in children under 18 years of age.

Method of administration

Intestifalk Uno should only be taken orally.

You should take Intestifalk Uno granules approximately ½ hour before breakfast. Place the granules directly on the tongue and swallow them with a glass of water. Do not chew the granulesas they will not work properly.

Duration of treatment

Your treatment should last approximately 8 weeks.

Your doctor will decide how long you need to continue using the medication, depending on your condition.

If you take moreIntestifalk Uno granulesthan you should

If you take too much medicine at one time, just take the next dose when it is due. Do not take a lower dose. If you are unsure, contact your doctor to decide what to do. If possible, take the pack and this leaflet with you.

If you forget to takeIntestifalk Uno granules

If you forget to take a dose, continue treatment with the prescribed dose. Do not take a double dose to make up for the forgotten dose.

If you stop takingIntestifalk Uno granules

Talk to your doctor if you want to stop or conclude your treatment beforehand.

It is important that you do not stop taking your medicine abruptly, as this could make you ill. Continue taking your medicine until your doctor tells you to, even if you start to feel better.

Your doctor will probably want to gradually reduce your dose, from one sachet daily to one sachet every other day, for at least two weeks.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If you experience any of the following symptoms after taking this medicine, you should contact your doctor immediately:

  • infection.
  • headache.
  • changes in behavior such as depression, irritability, euphoria, restlessness, anxiety, or aggression.

The following side effects have also been reported:

Common: may affect up to 1 in 10 people

  • Cushing's syndrome, for example, with rounded face, weight gain, reduced glucose tolerance, high blood sugar, high blood pressure, fluid retention in tissues (e.g., swollen legs), increased potassium excretion (hypokalemia), irregular periods in women, unwanted body hair in women, impotence, abnormal laboratory results (reduced adrenal function), red stretch marks on the skin, acne
  • Dyspepsia (indigestion, irritable stomach), abdominal pain
  • Increased risk of infection
  • Muscle and joint pain, muscle weakness, muscle spasms
  • Bone fragility (osteoporosis)
  • Headache
  • Mood changes, such as depression, irritability, or euphoria
  • Rash due to hypersensitivity reactions, red spots due to bleeding in the skin, delayed wound healing, local skin reactions such as contact dermatitis

Uncommon: may affect up to 1 in 100 people

  • Ulcers in the stomach or small intestine
  • Restlessness with increased physical activity, anxiety

Rare: may affect up to 1 in 1,000 people

  • Blurred vision
  • Pancreatitis
  • Bone loss due to poor blood circulation (osteonecrosis)
  • Aggression
  • Bruising

Very rare: may affect up to 1 in 10,000 people

  • Growth retardation in children
  • Constipation
  • Increased intracranial pressure, possibly with increased ocular pressure (inflammation of the optic disc) in adolescents
  • Increased risk of thrombosis, inflammation of blood vessels (associated with the end of cortisone administration after long-term treatment)
  • Fatigue, feeling of general malaise

These side effects are typical of steroid medicines and most of them are also predictable for treatments with other steroids. They may occur depending on the dose, duration of treatment, whether you have followed or are following treatment with other cortisone preparations, and your personal propensity.

If you have received treatment with a more potent cortisone preparation before starting treatment with Intestifalk Uno granules, your symptoms may recur when switching medicines.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Agency's website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Intestifalk Uno granules

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and sachets. The expiry date is the last day of the month stated.

This medicine does not require any special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

Composition ofIntestifalk Uno granules

  • The active substance is budesonide. Each sachet with gastro-resistant granules contains 9 mg of budesonide.
  • The other ingredients are ammonio methacrylate copolymer (type A) (Eudragit RL), ammonio methacrylate copolymer (type B) (Eudragit RS), citric acid, lactose monohydrate, lemon flavor, magnesium stearate, methacrylic acid-methyl methacrylate copolymer (1:1) (Eudragit L100), methacrylic acid-methyl methacrylate copolymer (1:2) (Eudragit S100), povidone K25, sucralose, sucrose, corn starch, sorbitol (E420), talc, triethyl citrate, xanthan gum (for more information on lactose, sucrose, and sorbitol, see section 2).

Appearance and pack contents

Intestifalk Uno granules are white to off-white gastro-resistant granules and white to pale yellow powderwith a lemon flavor, in a sachet.

Intestifalk Uno granules are available in pack sizes of 15, 20, 30, 50, and 60 sachets.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Dr. Falk Pharma GmbH

Leinenweberstr. 5

79108 Freiburg

Germany

Tel +49 (0) 761 / 1514-0

Fax +49(0) 761 / 1514-321

E-mail: [email protected]

You can obtain more information about this medicine by contacting the local representative of the marketing authorization holder:

Spain

Dr. Falk Pharma España

Camino de la Zarzuela, 19

28023 Madrid

This medicine is authorized in the Member States of the European Economic Area under the following names:

Germany, Belgium, Bulgaria, Czech Republic, Cyprus, Denmark, Slovakia, Slovenia, Finland, United Kingdom, Greece, Hungary, Ireland, Luxembourg, Norway, Netherlands, Portugal, Romania, Sweden: Budenofalk.

Austria: Budo-San.

France: MIKICORT

Italy: Intesticortmono

Spain: Intestifalk

Date of last revision of this leaflet: February 2021

Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for INTESTIFALK UNO 9 mg GASTRO-RESISTANT GRANULES

Discuss questions about INTESTIFALK UNO 9 mg GASTRO-RESISTANT GRANULES, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
5.0 (140)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50
5.0 (29)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60
5.0 (29)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for INTESTIFALK UNO 9 mg GASTRO-RESISTANT GRANULES?
INTESTIFALK UNO 9 mg GASTRO-RESISTANT GRANULES requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in INTESTIFALK UNO 9 mg GASTRO-RESISTANT GRANULES?
The active ingredient in INTESTIFALK UNO 9 mg GASTRO-RESISTANT GRANULES is budesonide. This information helps identify medicines with the same composition but different brand names.
How much does INTESTIFALK UNO 9 mg GASTRO-RESISTANT GRANULES cost in pharmacies?
The average pharmacy price for INTESTIFALK UNO 9 mg GASTRO-RESISTANT GRANULES is around 161.42 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures INTESTIFALK UNO 9 mg GASTRO-RESISTANT GRANULES?
INTESTIFALK UNO 9 mg GASTRO-RESISTANT GRANULES is manufactured by Dr. Falk Pharma Gmbh. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of INTESTIFALK UNO 9 mg GASTRO-RESISTANT GRANULES online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether INTESTIFALK UNO 9 mg GASTRO-RESISTANT GRANULES is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to INTESTIFALK UNO 9 mg GASTRO-RESISTANT GRANULES?
Other medicines with the same active substance (budesonide) include ENTOCORD 2 mg TABLETS AND SOLUTION FOR RECTAL SUSPENSION, ENTOCORD 3 mg MODIFIED-RELEASE CAPSULES, INTESTIFALK 2 mg/DOSE RECTAL FOAM. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media